ロード中...
Drug Industry Groups Oppose FDA “Quality Metrics” Plan: The Agency Wants to Use Manufacturing Data to Attack Drug Shortages
Raising their voices in nearly unanimous opposition, pharmaceutical manufacturers and their suppliers have mounted a campaign to dissuade the FDA from launching a voluntary program in 2018 that is aimed at reducing drug shortages.
保存先:
| 出版年: | P T |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MediMedia USA, Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5481295/ https://ncbi.nlm.nih.gov/pubmed/28674472 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|